Astrantus »

Fifth Third Ban shares owned by Astrantus

Quarter-by-quarter ownership of Fifth Third Ban (FITB) shares owned by Astrantus from 13F filings

Historical chart of Astrantus investment in Fifth Third Ban

Tip: Access up to 7 years of quarterly data

All positions including Fifth Third Ban held by Astrantus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fifth Third Ban by Astrantus

Quarter filed Position value Share count Share price at filing
2022-03-31 $461k 11k 43.08
2021-12-31 $331k 7.6k 43.59

More positions owned by Astrantus

Visa Inc. Class A Cl A (V)
Vale (VALE)
Verizon Communications (VZ)
Merck & Co (MRK)
Novartis (NVS)
At&t (T)
Johnson & Johnson (JNJ)
Boston Scientific Corporation (BSX)
Unilever (UL)
Abbott Laboratories (ABT)
Apple (AAPL)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Tor Dom Bk Cad (TD)
U.S. Bancorp (USB)

View all positions for Astrantus

Top funds holding Fifth Third Ban

Vanguard Group
BlackRock
T. Rowe Price Associates
Jpmorgan Chase & Co
Charles Schwab Investment Management
Geode Capital Management
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
Dimensional Fund Advisors
Allspring Global Investments Holdings
Nuveen Asset Management
First Trust Advisors
Royal Bank of Canada
Northern Trust

View all funds holding Fifth Third Ban